Toxoplasma gondii alters eicosanoid release by human mononuclear phagocytes: role of leukotrienes in interferon gamma-induced antitoxoplasma activity.
Open Access
- 1 November 1994
- journal article
- Published by Rockefeller University Press in The Journal of Experimental Medicine
- Vol. 180 (5), 1637-1648
- https://doi.org/10.1084/jem.180.5.1637
Abstract
Toxoplasma gondii tachyzoites markedly alter the profile of eicosanoids released by human mononuclear phagocytes. Freshly isolated, 2-h adherent human monocytes release both cyclooxygenase (e.g., thromboxane [TX] B2, prostaglandin [PG] E2) and 5-lipoxygenase (e.g., leukotriene [LT] B4, LTC4) products of arachidonic acid metabolism after stimulation by the calcium ionophore A23187 or ingestion of opsonized zymosan particles or heat-killed T. gondii. However, after incubation with viable T. gondii, normal and chronic granulomatous disease monocytes release only the cyclooxygenase products TXB2 and PGE2 and fail to form LTB4, LTC4, or other 5-lipoxygenase products. Monocytes maintained in culture for 5 d lose this capacity to release TXB2 and PGE2 after incubation with T. gondii. T. gondii significantly inhibit calcium ionophore A23187-induced LTB4 release by monocyte-derived macrophages; heat-killed organisms do not affect this calcium ionophore A23187-induced release of LTB4. T. gondii-induced inhibition of LTB4 release by calcium ionophore A23187-stimulated monocyte-derived macrophage is reversed by interferon (IFN)-gamma treatment of the monolayers. LTB4 induced extensive damage to the cellular membranes and cytoplasmic contents of the organisms as observed by transmission electron microscopy. Exogenous LTB4 (10(-6) M) induced intracellular killing of ingested T. gondii by non-IFN-gamma-treated monocyte-derived macrophages. IFN-gamma-induced antitoxoplasma activity in monocyte-derived macrophages was inhibited by the selective 5-lipoxygenase inhibitor zileuton but not by the cyclooxygenase inhibitor indomethacin. These findings suggest a novel role for 5-lipoxygenase arachidonic acid products in human macrophage IFN-gamma-induced antitoxoplasma activity.Keywords
This publication has 45 references indexed in Scilit:
- Lymphokines Enhance the Capacity of Human Monocytes to Secrete Reactive Oxygen IntermediatesJCI Insight, 1982
- Regulation of arachidonic acid metabolism by macrophage activation.The Journal of Experimental Medicine, 1982
- Hydrogen peroxide metabolism in human monocytes during differentiation in vitro.JCI Insight, 1981
- The diminished production of arachidonic acid oxygenation products by elicited mouse peritoneal macrophages: possible mechanisms.The Journal of Immunology, 1980
- Ultrastructural and cytochemical changes induced by short and prolonged culture of human monocytes.1980
- Activity of Human Blood Leukocytes against Toxoplasma gondiiThe Journal of Infectious Diseases, 1979
- Macrophage oxygen-dependent antimicrobial activity. II. The role of oxygen intermediates.The Journal of Experimental Medicine, 1979
- Differentiation of macrophages from normal human bone marrow in liquid culture. Electron microscopy and cytochemistry.JCI Insight, 1978
- Isolation of Lymphocytes, Granulocytes and MacrophagesScandinavian Journal of Immunology, 1976
- SPECIFIC ANTIBODY-DEPENDENT KILLING OF TOXOPLASMA-GONDII BY NORMAL MACROPHAGES1976